Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CDKAL1 Activators

CDKAL1 Activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of CDKAL1 through various signaling pathways and molecular interactions. ATP is fundamental for CDKAL1's kinase activity, providing the necessary phosphate groups, while the presence of essential cofactors like Mg2+ and Zn2+ is critical for its structural stability and substrate interactions. Inhibition of competitive binding sites by CDK inhibitors such as Roscovitine may bolster CDKAL1's phosphorylation events, thereby amplifying its role in cellular processes. Similarly, Forskolin's ability to raise cAMP levels indirectly promotes CDKAL1 activity through PKA-mediated pathways, which might affect CDKAL1's regulation of the cell cycle. The use of phosphatase like Sodium orthovanadate ensures the preservation of CDKAL1's phosphorylated substrates, thereby sustaining its function within the cell.

Moreover, compounds such as Retinoic acid and Trichostatin A (TSA) modulate cellular differentiation and chromatin structure, respectively, which could create a conducive environment for enhanced CDKAL1 activity. The modulation of the cellular redox state by NAD+ levels is another avenue through which CDKAL1's enzymatic function might be augmented. The impact of SP600125 on JNK signaling and LY294002 on PI3K/AKT pathways represents further indirect mechanisms by which CDKAL1 activity could be upregulated, considering its involvement in cell growth and proliferation. Lastly, 5-Azacytidine's role in altering geneexpression patterns may lead to an upsurge in proteins that govern or interact with CDKAL1, facilitating an increase in its functional activity. Collectively, these activators, through their targeted biochemical actions, support the enhancement of CDKAL1-mediated functions critical for cellular homeostasis and proliferation, without the need to directly upregulate its expression or activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine, a CDK inhibitor, can indirectly increase CDKAL1 activity by reducing competitive binding sites and shifting balance towards CDKAL1's involvement in phosphorylation events.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin elevates cAMP levels which could enhance CDKAL1 activity through cAMP-dependent protein kinase (PKA) pathways indirectly affecting CDKAL1's role in cell cycle regulation.

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
$49.00
$57.00
$187.00
142
(4)

As a phosphatase inhibitor, sodium orthovanadate prevents dephosphorylation, indirectly maintaining CDKAL1's function by preserving the phosphorylation state of its substrates.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid influences cell cycle progression and differentiation, pathways in which CDKAL1 plays a role, potentially enhancing its activity in these processes.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Zn2+ can act as a cofactor for many proteins, possibly enhancing the structural stability or interaction of CDKAL1 with its substrates or associated proteins.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

TSA, an HDAC inhibitor, changes the acetylation state of proteins, which could alter the interaction landscape of CDKAL1, potentially enhancing its activity.

NAD+, Free Acid

53-84-9sc-208084B
sc-208084
sc-208084A
sc-208084C
sc-208084D
sc-208084E
sc-208084F
1 g
5 g
10 g
25 g
100 g
1 kg
5 kg
$57.00
$191.00
$302.00
$450.00
$1800.00
$3570.00
$10710.00
4
(2)

NAD+ is essential for redox reactions, and its altered levels could influence CDKAL1 activity by changing the cellular redox state, affecting its enzymatic function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK inhibitor, SP600125 could alter cell signaling pathways, potentially leading to an indirect increase in CDKAL1 activity by shifting the balance of kinase activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

By inhibiting PI3K, LY294002 can affect downstream AKT signaling, indirectly influencing CDKAL1's role in cell growth and proliferation pathways.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor can change gene expression patterns, potentially increasing the expression of proteins that interact with or regulate CDKAL1, enhancing its activity.